Becton Dickinson ( ($BDX) ) has issued an announcement. On October 15, 2025, BD announced a CFO transition plan as Chris ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, proudly commemorates 65 years of ...

Key Insights The projected fair value for Becton Dickinson is US$341 based on 2 Stage Free Cash Flow to Equity ...

Becton Dickinson said on Wednesday that its Chief Financial Officer Chris DelOrefice will depart the company, effective December 5, after four years at the medical device maker.

Becton Dickinson CFO Chris DelOrefice will step down Dec. 5 as BD reports strong fiscal 2025 sales and appoints Vitor Roque interim CFO.

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter. The fund underperformed its benchmark, the MSCI World Index (net), in the second ...

FRANKLIN LAKES, N.J., Oct. 8, 2025 /PRNewswire/ -- (NYSE: BDX), a leading global medical technology company, and Opentrons ...

Fintel reports that on October 16, 2025, RBC Capital reiterated coverage of Becton, Dickinson and (NYSE:BDX) with a Sector ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned -5.78% in the ...

With a market cap of $64 billion, Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) is a global medical technology leader. Operating through three key segments: BD Medical; BD Life ...

Williams, and Becton, Dickinson and Company sport a market-doubling 2.5% dividend yield. Learn more about CVX, SHW, and BDX ...